PMFA
ALNY icon

Plante Moran Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Plante Moran Financial Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
636
+1
+0.2% +$302 0.01% 170
2026
Q1 		$210K Hold
635
– – 0.01% 156
2025
Q4 		$253K Sell
635
-2
-0.3% -$885 0.02% 152
2025
Q3 		$290K Sell
637
-648
-50% -$264K 0.02% 132
2025
Q2 		$419K Hold
1,285
– – 0.03% 96
2025
Q1 		$347K Buy
1,285
+650
+102% +$167K 0.03% 112
2024
Q4 		$149K Hold
635
– – 0.01% 208
2024
Q3 		$175K Sell
635
-465
-42% -$121K 0.01% 197
2024
Q2 		$267K Hold
1,100
– – 0.03% 142
2024
Q1 		$164K Hold
1,100
– – 0.02% 186
2023
Q4 		$211K Buy
+1,100
New +$187K 0.02% 161
2020
Q4 		– Sell
-100
Closed -$15K – 877
2020
Q3 		$15K Buy
+100
New +$14.2K 0.01% 542
2018
Q3 		– Sell
-16
Closed -$2K – 752
2018
Q2 		$2K Sell
16
-11
-41% -$1.09K ﹤0.01% 708
2018
Q1 		$3K Buy
27
+15
+125% +$1.93K ﹤0.01% 774
2017
Q4 		$2K Sell
12
-2
-14% -$251 ﹤0.01% 779
2017
Q3 		$2K Buy
+14
New +$1.2K ﹤0.01% 713
2017
Q2 		– Sell
-12
Closed -$1K – 827
2017
Q1 		$1K Sell
12
-42
-78% -$1.94K ﹤0.01% 813
2016
Q4 		$2K Hold
54
– – ﹤0.01% 841
2016
Q3 		$4K Sell
54
-6
-10% -$423 ﹤0.01% 725
2016
Q2 		$3K Hold
60
– – ﹤0.01% 702
2016
Q1 		$4K Buy
+60
New +$3.99K ﹤0.01% 604

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Plante Moran Financial Advisors's ALNY Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 0.16% in Q2 2026, buying an estimated $302 and bringing the position to 636 shares worth $191K. The position accounts for 0.01% of the portfolio, ranked #170.

Plante Moran Financial Advisors first reported a position in ALNY in Q1 2016 and has held it in 21 quarters since. The position peaked at $419K in Q2 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Plante Moran Financial Advisors held 636 shares of Alnylam Pharmaceuticals worth $191K as of Q2 2026.
  • Plante Moran Financial Advisors bought 1 Alnylam Pharmaceuticals share in Q2 2026, an estimated $302.
  • Alnylam Pharmaceuticals made up 0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #170 holding.
  • Plante Moran Financial Advisors first reported a position in Alnylam Pharmaceuticals in Q1 2016 and has held it in 21 quarters since.
  • Plante Moran Financial Advisors's Alnylam Pharmaceuticals position peaked at $419K in Q2 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.